{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:06:43Z","timestamp":1753884403843,"version":"3.41.2"},"reference-count":70,"publisher":"The Ewha Medical Journal, Ewha Womans University College of Medicine","issue":"1","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1C1C1005979"],"award-info":[{"award-number":["NRF-2022R1C1C1005979"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.e-emj.org"],"crossmark-restriction":true},"short-container-title":["Ewha Med J"],"DOI":"10.12771\/emj.2024.e4","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T07:10:46Z","timestamp":1708326646000},"update-policy":"https:\/\/doi.org\/10.12771\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of endocrine tumor syndromes manifesting as adrenal tumors"],"prefix":"10.12771","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-5199","authenticated-orcid":false,"given":"Ja Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4998","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"issue":"3","key":"key2.0240220102614e+13_B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"issue":"2","key":"key2.0240220102614e+13_B2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"issue":"5","key":"key2.0240220102614e+13_B3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2013.02.017","article-title":"Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg"},{"issue":"4","key":"key2.0240220102614e+13_B4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/etm.2022.11216","article-title":"Adrenocortical carcinoma: pediatric aspects (review)","volume":"23","author":"Sandru","year":"2022","journal-title":"Exp Ther Med"},{"issue":"3","key":"key2.0240220102614e+13_B5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6065\/apem.2142044.022","article-title":"Low-dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma","volume":"27","author":"Heo","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"key2.0240220102614e+13_B6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6065\/apem.2040240.120","article-title":"Patients with disorders of sex development","volume":"26","author":"Markosyan","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"key2.0240220102614e+13_B7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.6065\/apem.2244124.062","article-title":"Classic and backdoor pathways of androgen biosynthesis in human sexual development","volume":"27","author":"Lee","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"11","key":"key2.0240220102614e+13_B8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"key2.0240220102614e+13_B9","doi-asserted-by":"crossref","first-page":"101448","DOI":"10.1016\/j.beem.2020.101448","article-title":"Pediatric adrenocortical tumours","volume":"34","author":"Pinto","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"key2.0240220102614e+13_B10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"key2.0240220102614e+13_B11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.6065\/apem.2142150.075","article-title":"Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age","volume":"26","author":"Yoo","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"10","key":"key2.0240220102614e+13_B12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/a-2127-9292","article-title":"Clinical characteristics and long-term outcomes of adrenal tumors in children and adolescents","volume":"131","author":"Kim","year":"2023","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"23","key":"key2.0240220102614e+13_B13","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"12","key":"key2.0240220102614e+13_B14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10147-021-02011-w","article-title":"Medical guidelines for Li\u2013Fraumeni syndrome 2019, version 1.1","volume":"26","author":"Kumamoto","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"key2.0240220102614e+13_B15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"24","key":"key2.0240220102614e+13_B16","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"key2.0240220102614e+13_B17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","article-title":"Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li\u2013Fraumeni syndrome","volume":"30","author":"Amadou","year":"2018","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"key2.0240220102614e+13_B18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"key2.0240220102614e+13_B19","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"key2.0240220102614e+13_B20","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"key2.0240220102614e+13_B21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tem.2005.05.010","article-title":"Fetal adrenal development: insight gained from adrenal tumors","volume":"16","author":"Coulter","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"key2.0240220102614e+13_B22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.30064","article-title":"Risk of tumorigenesis in overgrowth syndromes: a comprehensive review","volume":"137C","author":"Lapunzina","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"key2.0240220102614e+13_B23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26432","article-title":"Management of adrenal masses in patients with Beckwith\u2013Wiedemann syndrome","volume":"64","author":"MacFarland","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"key2.0240220102614e+13_B24","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28042","article-title":"Adrenocortical carcinoma in atypical Beckwith-Wiedemann syndrome due to loss of methylation at imprinting control region 2","volume":"67","author":"Eltan","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"key2.0240220102614e+13_B25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Clinical and molecular diagnosis, screening and management of Beckwith\u2013Wiedemann syndrome: an international consensus statement","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"key2.0240220102614e+13_B26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"key2.0240220102614e+13_B27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key2.0240220102614e+13_B28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.6065\/apem.2142100.050","article-title":"Adrenocortical carcinoma and a sporadic MEN1 mutation in a 3-year-old girl: a case report","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"key2.0240220102614e+13_B29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14727","article-title":"Update on the clinical management of multiple endocrine neoplasia type 1","volume":"97","author":"Pieterman","year":"2022","journal-title":"Clin Endocrinol"},{"issue":"2","key":"key2.0240220102614e+13_B30","doi-asserted-by":"crossref","first-page":"bvac001","DOI":"10.1210\/jendso\/bvac001","article-title":"MEN1 surveillance guidelines: time to (re)think?","volume":"6","author":"Newey","year":"2022","journal-title":"J Endocr Soc"},{"issue":"5","key":"key2.0240220102614e+13_B31","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key2.0240220102614e+13_B32","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key2.0240220102614e+13_B33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"key2.0240220102614e+13_B34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","article-title":"The cAMP pathway and the control of adrenocortical development and growth","volume":"351","author":"de Joussineau","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"22","key":"key2.0240220102614e+13_B35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"key2.0240220102614e+13_B36","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key2.0240220102614e+13_B37","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"key2.0240220102614e+13_B38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcell.2015.00026","article-title":"PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors","volume":"3","author":"Berthon","year":"2015","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"key2.0240220102614e+13_B39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"key2.0240220102614e+13_B40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"issue":"7","key":"key2.0240220102614e+13_B41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP\u2013specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"key2.0240220102614e+13_B42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.6065\/apem.2346074.037","article-title":"Cushing disease in pediatrics: an update","volume":"28","author":"Concepci\u00f3n-Zavaleta","year":"2023","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"key2.0240220102614e+13_B43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fped.2017.00155","article-title":"Review of pediatric pheochromocytoma and paraganglioma","volume":"5","author":"Bholah","year":"2017","journal-title":"Front Pediatr"},{"issue":"1","key":"key2.0240220102614e+13_B44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-term prognosis of patients with pediatric pheochromocytoma","volume":"21","author":"Bausch","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"key2.0240220102614e+13_B45","doi-asserted-by":"crossref","first-page":"610746","DOI":"10.3389\/fendo.2020.610746","article-title":"Clinical presentation and treatment outcomes of children and adolescents with pheochromocytoma and paraganglioma in a single center in Korea","volume":"11","author":"Park","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6","key":"key2.0240220102614e+13_B46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","article-title":"Pheochromocytoma surgery: epidemiologic peculiarities in children","volume":"28","author":"Beltsevich","year":"2004","journal-title":"World J Surg"},{"issue":"3","key":"key2.0240220102614e+13_B47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1542\/peds.2005-2299","article-title":"Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center","volume":"118","author":"Pham","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"key2.0240220102614e+13_B48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"key2.0240220102614e+13_B49","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key2.0240220102614e+13_B50","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1210\/jc.2015-3045","article-title":"Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome","volume":"100","author":"Aufforth","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key2.0240220102614e+13_B51","doi-asserted-by":"crossref","first-page":"R293","DOI":"10.1530\/EC-21-0294","article-title":"Pheochromocytomas and paragangliomas in von Hippel\u2013Lindau disease: not a needle in a haystack","volume":"10","author":"Castro-Teles","year":"2021","journal-title":"Endocr Connect"},{"issue":"8","key":"key2.0240220102614e+13_B52","doi-asserted-by":"crossref","first-page":"T41","DOI":"10.1530\/ERC-19-0435","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop","volume":"27","author":"Dahia","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"key2.0240220102614e+13_B53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"key2.0240220102614e+13_B54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","article-title":"A review of von Hippel-Lindau syndrome","volume":"4","author":"Varshney","year":"2017","journal-title":"J Kidney Cancer VHL"},{"issue":"2","key":"key2.0240220102614e+13_B55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype\u2013phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"issue":"8","key":"key2.0240220102614e+13_B56","doi-asserted-by":"crossref","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","article-title":"von Hippel-Lindau disease: updated guideline for diagnosis and surveillance","volume":"65","author":"Binderup","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"5","key":"key2.0240220102614e+13_B57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/EJE-12-1106","article-title":"High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients","volume":"168","author":"Imai","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key2.0240220102614e+13_B58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000658-199306000-00001","article-title":"Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes","volume":"217","author":"Lairmore","year":"1993","journal-title":"Ann Surg"},{"issue":"12","key":"key2.0240220102614e+13_B59","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archsurg.141.12.1199","article-title":"Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A","volume":"141","author":"Asari","year":"2006","journal-title":"Arch Surg"},{"issue":"3","key":"key2.0240220102614e+13_B60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"key2.0240220102614e+13_B61","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Thosani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key2.0240220102614e+13_B62","doi-asserted-by":"crossref","first-page":"101818","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"11","key":"key2.0240220102614e+13_B63","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/cells9112365","article-title":"Neurofibromin structure, functions and regulation","volume":"9","author":"Bergoug","year":"2020","journal-title":"Cells"},{"issue":"1","key":"key2.0240220102614e+13_B64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"5","key":"key2.0240220102614e+13_B65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"key2.0240220102614e+13_B66","first-page":"95","article-title":"Clinical presentation and outcomes of phaeochromocytomas\/paragangliomas in neurofibromatosis type 1","volume":"15","author":"Al-Sharefi","year":"2019","journal-title":"Eur Endocrinol"},{"issue":"4","key":"key2.0240220102614e+13_B67","doi-asserted-by":"crossref","first-page":"302","DOI":"10.6065\/apem.2244016.008","article-title":"Metanephrine negative pheochromocytoma: a rare case report of dopamine-secreting tumor in an adolescent neurofibromatosis type 1 patient","volume":"28","author":"Lee","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"key2.0240220102614e+13_B68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beem.2010.04.001","article-title":"SDH-related pheochromocytoma and paraganglioma","volume":"24","author":"Kantorovich","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"key2.0240220102614e+13_B69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"key2.0240220102614e+13_B70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/gcc.1144","article-title":"Nearly all hereditary paragangliomas in The Netherlands are caused by two founder mutations in the SDHD gene","volume":"31","author":"Taschner","year":"2001","journal-title":"Genes Chromosomes Cancer"}],"container-title":["The Ewha Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2024.e4","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2024.e4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T02:08:10Z","timestamp":1741226890000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2024.e4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,31]]}},"alternative-id":["10.12771\/emj.2024.e4"],"URL":"https:\/\/doi.org\/10.12771\/emj.2024.e4","relation":{},"ISSN":["2234-2591"],"issn-type":[{"type":"electronic","value":"2234-2591"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"2023-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e4"}}